Number (%) of new syndesmophytes after 2 years on radiographs of anterior cervical and lumbar spine in a clinical trial cohort of 76 patients with ankylosing spondylitis receiving adalimumab stratified according to the type of CIL and its persistence/resolution with treatment
| New syndesmophytes or ankylosis at 2 years | ||
|---|---|---|
| No | Yes | |
| Total resolved CIL | 151 (96.2) | 6 (3.8) |
| Resolved CIL type A | 126 (98.4) | 2 (1.6) |
| Resolved CIL type B | 25 (86.2) | 4 (13.8)* |
| Total persistent CIL | 56 (88.9) | 7 (11.1)† |
| Persistent CIL type A | 41 (93.2) | 3 (6.8) |
| Persistent CIL type B | 15 (78.9) | 4 (21.1)‡ |
| No VC CIL or fat | 980 (98.2) | 18 (1.8) |